SBRA
Company Description
As of March 31, 2022, Sabra Health Care REIT, Inc. held a diverse investment portfolio. This largely comprised 416 income-generating real estate properties, which included: 279 skilled nursing and transitional care facilities; 59 senior living communities operating under lease agreements; 50 senior housing properties managed by external operators; 13 behavioral health centers; and 15 specialized hospitals and other healthcare sites. In addition to its real estate holdings, Sabra's portfolio also featured: a single asset earmarked for sale; one sales-type lease arrangement; a total of 16 loan receivables, consisting of two mortgage loans, one construction loan, and thirteen other debt instruments; seven preferred equity stakes; and an interest in one unconsolidated joint venture. Collectively, these 416 investment properties offered a capacity of 41,445 beds and residential units, geographically distributed across both the United States and Canada.
Track Record
| Metric | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 774.63M | 703.24M | 647.51M | 624.81M | 569.54M | 598.57M | 668.18M | 623.41M | 405.65M | 260.53M | 238.86M | 183.52M |
| Net Income | 155.61M | 126.71M | 13.76M | (77.61M) | (113.26M) | 138.42M | 69.00M | 279.08M | 158.38M | 70.28M | 79.41M | 46.95M |
| EPS | 0.64 | 0.54 | 0.06 | -0.34 | -0.52 | 0.67 | 0.37 | 1.57 | 1.40 | 0.92 | 1.11 | 0.79 |
| Free Cash Flow | 348.61M | 310.54M | 300.57M | 315.73M | 322.78M | 249.26M | 372.48M | 451.89M | (200.64M) | 176.74M | 121.10M | 85.34M |
| FCF / Share | 1.44 | 1.33 | 1.30 | 1.37 | 1.47 | 1.21 | 1.99 | 2.53 | -1.90 | 2.71 | 1.95 | 1.84 |
| Operating CF | 348.61M | 310.54M | 300.57M | 315.73M | 356.39M | 354.85M | 372.48M | 358.54M | 133.49M | 176.74M | 121.10M | 85.34M |
| Total Assets | 5.49B | 5.30B | 5.39B | 5.75B | 5.97B | 5.99B | 6.07B | 6.67B | 7.03B | 2.27B | 2.49B | 2.06B |
| Total Debt | 2.55B | 2.44B | 2.45B | 2.55B | 2.44B | 2.43B | 2.48B | 3.23B | 3.39B | 1.21B | 1.40B | 1.09B |
| Cash & Equiv | 71.54M | 60.47M | 41.28M | 49.31M | 112.00M | 59.08M | 39.10M | 50.23M | 518.63M | 25.66M | 7.43M | 61.79M |
| Book Value | 2.82B | 2.74B | 2.80B | 3.06B | 3.38B | 3.41B | 3.49B | 3.25B | 3.43B | 1.02B | 1.05B | 941.87M |
| Return on Equity | 0.06 | 0.05 | 0.00 | -0.03 | -0.03 | 0.04 | 0.02 | 0.09 | 0.05 | 0.07 | 0.08 | 0.05 |
| Metric | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 221.75M | 211.90M | 190.04M | 189.15M | 183.54M | 182.35M | 178.00M | 176.14M | 166.75M | 163.40M | 160.98M | 160.51M |
| Net Income | 40.88M | 27.23M | 22.54M | 65.54M | 40.30M | 46.70M | 29.79M | 23.98M | 26.25M | 17.16M | (15.10M) | 21.19M |
| EPS | 0.16 | 0.11 | 0.09 | 0.28 | 0.17 | 0.20 | 0.13 | 0.10 | 0.11 | 0.07 | -0.07 | 0.09 |
| Free Cash Flow | 98.36M | 87.43M | 99.96M | 80.96M | 80.26M | 79.97M | 97.65M | 80.13M | 52.80M | 78.74M | 2.59M | 70.33M |
| FCF / Share | 0.39 | 0.35 | 0.42 | 0.34 | 0.34 | 0.34 | 0.42 | 0.35 | 0.23 | 0.34 | 0.01 | 0.30 |
| Operating CF | 98.36M | 87.43M | 99.96M | 80.96M | 80.26M | 79.97M | 97.65M | 80.13M | 52.80M | 78.74M | 83.22M | 70.33M |
| Total Assets | 5.59B | 5.49B | 5.56B | 5.33B | 5.23B | 5.30B | 5.37B | 5.35B | 5.37B | 5.39B | 5.38B | 5.52B |
| Total Debt | 2.69B | 2.55B | 2.61B | 2.50B | 2.42B | 2.44B | 2.50B | 2.48B | 2.49B | 2.45B | 2.38B | 2.46B |
| Cash & Equiv | 123.45M | 71.54M | 200.60M | 95.17M | 22.65M | 60.47M | 63.00M | 36.40M | 59.93M | 41.28M | 33.26M | 27.23M |
| Book Value | 2.79B | 2.82B | 2.82B | 2.71B | 2.70B | 2.74B | 2.74B | 2.76B | 2.77B | 2.80B | 2.87B | 2.94B |
| Return on Equity | 0.01 | 0.01 | 0.01 | 0.02 | 0.01 | 0.02 | 0.01 | 0.01 | 0.01 | 0.01 | -0.01 | 0.01 |